2024 年至 2032 年即時血糖測試市場機會、成長動力、產業趨勢分析與預測

Point-of-Care Glucose Testing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032

出版日期: 2024年09月03日 | 出版商:

Global Market Insights Inc. | 英文 85 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球即時血糖測試市場價值為 34 億美元，預計 2024 年至 2032 年複合年成長率為 4.7%。管理。與連續血糖監測系統和先進感測器技術整合等創新正在改變血糖水平監測和管理。 2023 年 2 月，Dexcom 推出了新一代 Dexcom G7 CGM 系統，其感測器比其前身 G6 小 60%。 G7 直接向智慧型手機或智慧手錶提供即時血糖資料，無需進行指尖採血測試。它專為患有 1 型、2 型或妊娠糖尿病的個體而設計。

許多即時血糖儀現在都具有藍牙或 Wi-Fi 功能，可將資料無縫傳輸到智慧型手機、平板電腦或雲端平台。這增強了資料管理並支援醫療保健專業人員進行遠端監控。 Abbott 的 FreeStyle Libre 3 透過緊湊型感測器提供即時血糖讀數，並與 FreeStyle LibreLink 應用程式整合以進行連續追蹤和資料共享。市場依產品類型分為採血裝置、測試條及血糖儀。

預計到 2032 年，試紙市場將達到 23 億美元。測試條的使用者友善設計只需最少的培訓，使患者和醫療保健提供者都可以使用它們。該過程包括將少量血液樣本放在試紙上並將其插入血糖儀中，以方便使用。市場依最終用途分為醫院、診所、診斷中心、家庭護理機構和其他最終用戶。

市場範圍
開始年份	2023年
預測年份	2024-2032
起始值	34億美元
預測值	51 億美元
複合年成長率	4.7%

到 2023 年，家庭護理環境細分市場將達到 13 億美元。它們讓糖尿病患者在家中方便地管理自己的病情，減少經常去醫療機構就診的需要。預計從 2024 年到 2032 年，英國的即時血糖檢測市場將顯著成長。國家醫療服務體系 (NHS) 為整合新醫療技術提供了全面的框架，包括即時照護 (POC) 血糖檢測系統。許多大學和研究機構專注於推進診斷技術，包括血糖監測。這項研究有助於開發更準確、更有效率且方便用戶使用的即時血糖測試設備。

產業生態系統分析
產業影響力
- 成長動力
  - 糖尿病盛行率增加
  - 血糖監測技術進步
  - 老年人口不斷增加
  - 連續血糖監測儀的採用越來越多
- 產業陷阱與挑戰
  - 先進設備成本高
  - 嚴格的監管挑戰
成長潛力分析
技術景觀
監管環境
未來市場趨勢
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品類型，2021 - 2032

主要趨勢
採血裝置
試紙條
血糖儀

第 6 章：市場估計與預測：按最終用途分類，2021 - 2032 年

主要趨勢
醫院
診所
診斷中心
家庭護理設置
其他最終用戶

第 7 章：市場估計與預測：按地區分類，2021 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 8 章：公司簡介

Abbott Laboratories
ARKRAY, Inc.
ACON Laboratories, Inc.
B. Braun Melsungen AG
Dexcom, Inc.
EKF Diagnostics Holdings plc
F. Hoffmann-La Roche Ltd.
Medtronic plc
Nipro Corporation
Nova Biomedical Corporation
PHC Holdings
Prodigy Diabetes Care, LLC.
Platinum Equity Advisors, LLC.
Sanofi
Sinocare

簡介目錄

Product Code: 11241

The Global Point-of-Care Glucose Testing Market was valued at USD 3.4 billion in 2023 and is projected to grow at a CAGR of 4.7% from 2024 to 2032. Recent advancements in point-of-care (POC) glucose testing have significantly improved the accuracy, convenience, and management of diabetes. Innovations such as integration with continuous glucose monitoring systems and advanced sensor technologies are transforming glucose level monitoring and management. In February 2023, Dexcom launched its next-generation Dexcom G7 CGM System, featuring a sensor 60% smaller than its predecessor, the G6. The G7 provides real-time glucose data directly to smartphones or smartwatches, eliminating the need for fingerstick tests. It is designed for individuals with type 1, type 2, or gestational diabetes.

Many point-of-care glucose meters now include Bluetooth or Wi-Fi capabilities for seamless data transfer to smartphones, tablets, or cloud platforms. This enhances data management and enables remote monitoring by healthcare professionals. Abbott's FreeStyle Libre 3 offers real-time glucose readings through a compact sensor and integrates with the FreeStyle LibreLink app for continuous tracking and data sharing. The market is segmented by product type into lancing devices, test strips, and blood-glucose meters.

The test strips segment is forecasted to reach USD 2.3 billion by 2032. Test strips offer high accuracy and precision in glucose measurement, which is essential for effective diabetes management. The user-friendly design of test strips requires minimal training, making them accessible for both patients and healthcare providers. The process involves placing a small blood sample on the strip and inserting it into a glucose meter, facilitating ease of use. The market is bifurcated by end-use into hospitals, clinics, diagnostic centers, home care settings, and other end-users.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$3.4 Billion
Forecast Value	$5.1 Billion
CAGR	4.7%

The home care settings segment accounted for USD 1.3 billion in 2023. Home care settings offer significant advantages for point-of-care glucose testing. They allow individuals with diabetes to manage their condition conveniently from home, reducing the need for frequent healthcare facility visits. The point-of-care glucose testing market in the UK is expected to experience significant growth from 2024 to 2032. The UK benefits from a well-established and sophisticated healthcare infrastructure. The National Health Service (NHS) provides a comprehensive framework for the integration of new medical technologies, including point-of-care (POC) glucose testing systems.The UK is a hub for medical research and innovation. Numerous universities and research institutions focus on advancing diagnostic technologies, including glucose monitoring. This research contributes to the development of more accurate, efficient, and user-friendly point-of-care glucose testing devices.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of diabetes
  - 3.2.1.2 Technological advancements in glucose monitoring
  - 3.2.1.3 Rising geriatric population
  - 3.2.1.4 Growing adoption of continuous glucose monitors
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of advanced devices
  - 3.2.2.2 Stringent regulatory challenges
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Regulatory landscape
3.6 Future market trends
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Lancing devices
5.3 Test strips
5.4 Blood-glucose meter

Chapter 6 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Hospitals
6.3 Clinics
6.4 Diagnostic centers
6.5 Home care settings
6.6 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.3.7 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa